ANIXA BIOSCIENCES, INC. Impairment of Intangible Assets, Finite-lived
ANIXA BIOSCIENCES, INC. (ANIX) had Impairment of Intangible Assets, Finite-lived of $168.00 thousand as of 2019-01-31, per its 10-K filed 2020-01-09.
Discontinued › Notes
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2020-01-09
- 2019-01-31: Impairment of Intangible Assets, Finite-lived $168.00K.
- 2018-10-31: Impairment of Intangible Assets, Finite-lived $838.00K.
| Period end | Impairment of Intangible Assets, Finite-lived |
|---|---|
| 2019-01-31 | $168.00K 10-K · filed 2020-01-09 |
| 2018-10-31 | $838.00K 10-K · filed 2020-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |